Ignite Creation Date:
2025-12-24 @ 5:37 PM
Ignite Modification Date:
2026-01-25 @ 3:28 PM
Study NCT ID:
NCT05035368
Status:
WITHDRAWN
Last Update Posted:
2023-12-22
First Post:
2021-08-30
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Ladarixin as Adjunctive Therapy to Improve Insulin Sensitivity and Glucometabolic Outcomes in Type 1 Diabetes
Sponsor:
Dompé Farmaceutici S.p.A
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
LDX0121
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None